LIFE – atyr pharma, inc. (US:NASDAQ)
Stock Stats
News
aTyr Pharma, Inc. (NASDAQ: LIFE) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $35.00 price target on the stock.
aTyr Pharma Announces First Quarter 2024 Results and Provides Corporate Update [Yahoo! Finance]
aTyr Pharma Announces First Quarter 2024 Results and Provides Corporate Update
aTyr Pharma Insiders Placed Bullish Bets Worth US$514.6k [Yahoo! Finance]
aTyr Pharma to Participate in April Investor Conferences
Form 10-Q aTYR PHARMA INC For: Mar 31
Form 8-K aTYR PHARMA INC For: May 02
Form ARS aTYR PHARMA INC For: Dec 31
Form DEFA14A aTYR PHARMA INC
Form DEF 14A aTYR PHARMA INC For: May 22
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.